Anxiety DisorderNCT01453452
S1008: Exercise, Diet, & Counseling in Improving Weight Loss in Overweight Female Breast or Colorectal Cancer Survivors
A study testing behavioral dietary intervention, exercise intervention and counseling intervention in people with Anxiety Disorder and Breast Cancer, run by SWOG Cancer Research Network at 58 sites in United States.
Trial summary
RATIONALE: Physical activity, diet, and counseling may help breast and colorectal cancer survivors to lose weight and improve their quality of life. PURPOSE: This phase II trial studies how well exercise, diet, and counseling work in improving physical activity and weight loss in overweight women who are breast and… Read more about this study
- Who is it for?
- Ages Up to 120 years, women only
- Conditions the study is for
- Anxiety Disorder, Breast Cancer, Cognitive/Functional Effects
- What is being tested?
- behavioral dietary intervention, exercise intervention and counseling intervention
- Type of treatment
- Surgery or procedure, Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 50 participants
- Where
- 58 sitesUnited States
- Study dates
- Mar 2012to Jan 2017
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Up to 120 years
- Women only
- No healthy volunteers
- Child, Adult, Older adult
DISEASE CHARACTERISTICS:
- Participants must be women with a previous diagnosis of stage I, II, or III invasive breast cancer or colorectal cancer
- Participants must have no evidence of disease at the time of registration and no history of metastases (M0)
- Participants must have a body mass index ≥ 25 kg/m^2 measured within 28 days of registration
- Participants must be considered sedentary (defined as < 60 minutes of moderate to vigorous physical activity per week; moderate exercise defined as exercising to the point of sweating)
- Participants must be willing to submit blood samples for biomarkers (insulin, glucose, HgbA1C, estradiol, and testosterone) and undergo DXA scans, and must be given the option to consent for specimen submission for banking and future translational medicine studies
- Participants must be willing and able to attend a Curves fitness center at least 3 times per week for 12 months
PATIENT CHARACTERISTICS:
- Participants must be post-menopausal, as defined by at least one of the following:
- At least 12 months since the last menstrual period
- Prior bilateral oophorectomy
- Previous hysterectomy with one or both ovaries left in place (or previous hysterectomy in which documentation of bilateral oophorectomy is unavailable) AND follicle-stimulating hormone (FSH) values consistent with the institutional normal values for the post-menopausal state
- If participant is under the age of 55, FSH levels must be obtained within 28 days prior to registration
- Zubrod performance status of 0
- Participants must have no abnormal changes on a regular (non-nuclear) cardiovascular exercise stress test (using a treadmill or bicycle) as measured by electrocardiogram (EKG)
- EKG must be within institutional limits of normal
- Results of previous cardiac exercise stress test may be used as long as it was done within 3 months prior to registration
- Participants must not have evidence of uncontrolled hypertension
- Participants with diabetes, pre-diabetes, and/or metabolic syndrome must have HgbA1C ≤ 8% within the past 28 days
- Current use of diabetes medications is allowed
- No other prior malignancy is allowed except for adequately treated basal cell or squamous cell skin cancer, in situ cervical cancer, or other cancer for which the participant has been disease-free for > 5 years
- Participants must not be active smokers within past 90 days; active smoking is defined as any smoking, even a puff
- Participants must have regular access to the internet in order to receive monthly nutrition-program newsletter e-mails and to complete study questionnaires online
- Participants must be able to understand, speak, and read English
- Participants must have a home phone or cell phone and agree to participate in the 14 (40-minute) behavioral counseling sessions and 9 (20-30-minute) telephone interviews
- Participants must have a baseline physical exam and physician clearance (primary care provider, medical oncologist, or surgical oncologist) to participate in the weight loss and exercise prior to enrollment within 60 days of registration; copy of physician clearance document must be submitted
PRIOR CONCURRENT THERAPY:
- Participants must be 90 days to 730 days post-surgery, chemotherapy, and radiation therapy
- Current hormonal therapy is allowed among breast cancer participants
- Other concurrent anti-cancer therapies, including Herceptin, are not allowed
- Surgery is defined as any major surgical procedure (resection or reconstructive) that would preclude inclusion in the exercise program
- If the participant has had a remedial surgical procedure (e.g., revision of reconstruction) or persistent complications from her original operation, approval will be obtained from the participant's surgeon prior to enrollment
- Persistent complications may include, but are not limited to, prolonged wound healing, hernias, or ostomy prolapse
Trial locations and contacts
58 sites in 1 country.
58 sites in 1 country
United States58 sites
Kaiser Permanente-Deer Valley Medical Center
Antioch, California, 94531
Cancer Center of Kansas - Chanute
Chanute, Kansas, 66720
Cancer Center of Kansas - Dodge City
Dodge City, Kansas, 67801
Swedish Medical Center-Edmonds
Edmonds, Washington, 98026
Cancer Center of Kansas - Fort Scott
Fort Scott, Kansas, 66701
Kaiser Permanente, Fremont
Fremont, California, 94538
Kaiser Permanente
Fresno, California, 93720
Cancer Centers of the Carolinas - Faris
Greenville, South Carolina, 29605
Cancer Centers of the Carolinas - Grove Commons
Greenville, South Carolina, 29605
Greenville Memorial Hospital
Greenville, South Carolina, 29605
Greenville CCOP
Greenville, South Carolina, 29615
Cancer Centers of the Carolinas-Greer Medical Oncology
Greer, South Carolina, 29650
Kaiser Permanente, Hayward
Hayward, California, 94545
Kaiser Permanente Moanalua Medical Center
Honolulu, Hawaii, 96819
Cancer Center of Kansas-Independence
Independence, Kansas, 67301
University of Kansas Medical Center
Kansas City, Kansas, 66160
Cancer Center of Kansas-Kingman
Kingman, Kansas, 67068
Lawrence Memorial Hospital
Lawrence, Kansas, 66044
Cancer Center of Kansas-Liberal
Liberal, Kansas, 67901
Loyola University Medical Center
Maywood, Illinois, 60153
Kaiser Permanente-Modesto
Modesto, California, 95356
Columbia University Medical Center
New York, New York, 10032
Cancer Center of Kansas - Newton
Newton, Kansas, 67114
Kaiser Permanente-Oakland
Oakland, California, 94611
Cancer Center of Kansas - Parsons
Parsons, Kansas, 67357
Cancer Center of Kansas - Pratt
Pratt, Kansas, 67124
Kaiser Permanente-Redwood City
Redwood City, California, 94063
Kaiser Permanente-Richmond
Richmond, California, 94801
Kaiser Permanente-Roseville
Roseville, California, 95661
William Beaumont Hospital
Royal Oak, Michigan, 48073
Kaiser Permanente-South Sacramento
Sacramento, California, 95823
Kaiser Permanente - Sacramento
Sacramento, California, 95825
Cancer Center of Kansas - Salina
Salina, Kansas, 67401
Southwest Oncology Group
San Antonio, Texas, 78245
Kaiser Permanente-San Francisco
San Francisco, California, 94115
Kaiser Permanente-Santa Teresa-San Jose
San Jose, California, 95119
Kaiser Permanente-San Rafael
San Rafael, California, 94903
Kaiser Permanente Medical Center - Santa Clara
Santa Clara, California, 95051
Kaiser Permanente-Santa Rosa
Santa Rosa, California, 95403
Swedish Medical Center-First Hill
Seattle, Washington, 98122-4307
University of Washington Medical Center
Seattle, Washington, 98195
Cancer Centers of the Carolinas - Seneca
Seneca, South Carolina, 29672
Kaiser Permanente-South San Francisco
South San Francisco, California, 94080
Cancer Centers of the Carolinas - Spartanburg
Spartanburg, South Carolina, 29307
Kaiser Permanente-Stockton
Stockton, California, 95210
William Beaumont Hospital - Troy
Troy, Michigan, 48098
Arizona Cancer Center at University Medical Center North
Tucson, Arizona, 85719
University of Arizona Health Sciences Center
Tucson, Arizona, 85724
Kaiser Permanente Medical Center-Vacaville
Vacaville, California, 95688
Kaiser Permanente-Vallejo
Vallejo, California, 94589
Kaiser Permanente-Walnut Creek
Walnut Creek, California, 94596
Cancer Center of Kansas - Wellington
Wellington, Kansas, 67152
Associates In Womens Health
Wichita, Kansas, 67208
Cancer Center of Kansas-Wichita Medical Arts Tower
Wichita, Kansas, 67208
Cancer Center of Kansas - Main Office
Wichita, Kansas, 67214
Via Christi Regional Medical Center
Wichita, Kansas, 67214
Wichita CCOP
Wichita, Kansas, 67214
Cancer Center of Kansas - Winfield
Winfield, Kansas, 67156
About this study
Official title: S1008: Feasibility Study of a Physical Activity and Dietary Change Weight Loss Intervention In Breast and Colorectal Cancer Survivors, Phase II
RATIONALE: Physical activity, diet, and counseling may help breast and colorectal cancer survivors to lose weight and improve their quality of life.
PURPOSE: This phase II trial studies how well exercise, diet, and counseling work in improving physical activity and weight loss in overweight women who are breast and colorectal cancer survivors.
Read the detailed description
OBJECTIVES:
Primary
- To determine the feasibility of a 12-month community-based combined physical activity and dietary change weight-loss intervention in overweight and sedentary female breast and colorectal cancer survivors recruited via the Southwest Oncology Group (SWOG).
- To estimate the effect size of the intervention on weight loss at 12 months.
Secondary
- To measure changes in anthropometric measures from baseline (body mass index [BMI], waist and hip circumference) at 6 and 12 months and body composition (% body fat as assessed by dual-energy X-ray absorptiometry [DXA] scan) at 12 months.
- To measure changes in minutes spent per week in moderate-to-vigorous aerobic activity from baseline using Curves attendance records and a 7-day physical activity assessment at 6 and 12 months.
- To measure changes from baseline to 6 and 12 months in dietary intake of carotenoids via serum carotenoid measures.
- To assess changes from baseline to 6 and 12 months in perceived benefit of dietary change, physical activity, and weight loss after a cancer diagnosis.
- To measure changes from baseline in metabolic and hormonal biomarkers associated with breast and colorectal cancer recurrence risk (fasting insulin, fasting glucose, hemoglobin A1C, bioavailable estradiol, free testosterone, and adiponectin) at 6 and 12 months.
- To assess changes from baseline in anxiety, depression, fatigue, sleep, satisfaction with social roles, pain, and physical function using the PROMISE-43 at 6 and 12 months.
- To assess baseline predictors (medical history, health behaviors, quality of life) of subjects who adhere to and complete the intervention.
- To assess the diversity of subjects who enroll and complete the intervention.
- To assess the availability and acceptability of the Curves fitness centers at 12 months.
- To explore changes in DNA methylation.
- To assess the intervention and study process via open-ended interviews with SWOG sites and Curves franchises.
- To measure changes in anthropometric measures and assess feasibility of extended follow-up at 24 and 36 months.
- To assess the safety of the Curves® fitness centers for this population by assessing self-reported changes in lymphedema and any injuries as measured at 6 and 12 months.
OUTLINE: Participants are stratified according to type of cancer (breast vs colorectal).
Participants are instructed to practice 30-45 minutes of medium-to-hard exercise 5-7 days a week at a Curves fitness center (paid by study) or outside Curves for 12 months. Participants receive written materials on physical activity guidelines for survivors and a pedometer to track their physical activity outside Curves. They also receive the Curves Fitness \& Weight Management Plan and are instructed to follow a "higher carbohydrate" diet plan, which promotes a 1,500 kcal/day diet that is high in fruit and vegetables consisting of 30% protein, 45% carbohydrates, and 25% fat. In addition, participants receive the dietary guidelines for cancer survivors, which recommend eating 5 or more servings of fruit/vegetables per day, a diet high in whole grains, low in saturated fat, low in sugary foods, and low in alcohol. Participants receive 14 behavioral-counseling sessions by telephone with the goal to increase intervention adherence and participation retention. Each session lasts 40 minutes and occurs weekly on weeks 1-5 and then every 6 weeks by month 6. Participants receive monthly email newsletters with health tips and motivational messages to encourage adherence and retention to the study program. Counselors also conduct three 24-hour dietary recall assessments and 1 physical activity assessment at 6 and 12 months.
Participants complete a PROMIS-43 quality-of-life questionnaire at 6 and 12 months via internet, mail, or telephone.
Participants also undergo blood sample collection at baseline and at 6 and 12 months for fasting glucose and insulin tests, and biomarker studies. Anthropometric measurements (height, weight, waist, and hip circumference) are also collected.
After completion of study intervention, participants are followed up at 24 and 36 months.
- Conditions
- Anxiety Disorder, Breast Cancer, Cognitive/Functional Effects, Colorectal Cancer, Depression, Fatigue
- Being tested
- behavioral dietary intervention, exercise intervention, counseling intervention, quality-of-life assessment
- Keywords
- weight changes, fatigue, depression, anxiety disorder, pain, cognitive/functional effects, psychosocial effects of cancer and its treatment, cancer survivor, stage IA breast cancer, stage IB breast cancer, stage II breast cancer, stage IIIA breast cancer, stage IIIB breast cancer, stage IIIC breast cancer, stage I colon cancer, stage IIA colon cancer, stage IIB colon cancer, stage IIC colon cancer, stage IIIA colon cancer, stage IIIB colon cancer
- Medical subject headings
- Anxiety Disorders, Breast Neoplasms, Colorectal Neoplasms, Depression, Fatigue, Pain, Body Weight Changes, Colonic Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
behavioral dietary interventionBehavioural
Reduce caloric intake by 500 kcal/day, increase fruit and vegetable intake to 5 or more servings per day, and limit daily calories from fat to be < 30%. Diet will be measured using 3 repeated 24-hr diet recalls. Participants will receive information on the recommended dietary modifications via mailed materials and telephone counseling sessions.
exercise interventionBehavioural
150 min/wk of moderate exercise through use of the Curves® centers, engage in physical activity outside of Curves®, and use pedometers to track activity.
counseling interventionOther
14 40-min behavioral counseling sessions via telephone with the goal of increasing intervention adherence and increasing participant retention.
quality-of-life assessmentProcedure or surgery
PROMIS-43 - online questionnaire to assess quality of life.
| Study group | Role | What they receive |
|---|---|---|
| Exercise and Lifestyle counseling | Experimental | Patients will receive behavioral dietary intervention \& counseling intervention by phone, exercise intervention at Curves(R) facility, and take a quality-of-life assessment online. Receives: Behavioral: behavioral dietary intervention; Behavioral: exercise intervention; Other: counseling intervention; Procedure: quality-of-life assessment |
What is being measured
The primary outcome is the main question the study is designed to answer.
Attendance of ≥ 2 Curves sessions/week for a minimum of 36 of the 52 weeks of intervention
Measured: 1 year from registration
Increase in fruit and vegetable consumption by 1 full serving per day (not including iceberg lettuce, potatoes, or fruit juices) OR reduce caloric intake by 100 kcal/day
Measured: 1 year from registration
Secondary outcomes (7)
Changes in anthropometric measures (weight, BMI, waist circumference, hip circumference)
Measured: 1 year from registration
Changes in body composition (% body fat as assessed by DXA scan at 12 months only)
Measured: 1 year from registration
Changes in minutes spent per week in moderate-to-vigorous intensity aerobic activity using Curves attendance records and a 7-day physical activity recall assessment
Measured: 1 year from registration
Changes in dietary intake patterns based on three separate 24-hour diet recalls
Measured: 1 year from registration
Changes in metabolic and hormonal biomarkers associated with breast and colorectal cancer-recurrence risk (fasting insulin, fasting glucose, hemoglobin A1C, bioavailable estradiol, free testosterone, and adiponectin)
Measured: 3 years
Changes in anxiety, depression, fatigue, sleep, satisfaction with social roles, pain, and physical function as measured by the PROMIS-43
Measured: 1 year from registration
DNA methylation patterns
Measured: 3 years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Oct 2011 (estimated)
- Study startMar 2012
- Primary completionAug 2015
- Study completionJan 2017
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Anxiety DisorderStudies of the same condition, open and under way.
- More trials run by SWOG Cancer Research NetworkThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 50 participants (actual)
Sponsor and investigators
- Lead sponsor
- SWOG Cancer Research Network
- Sponsor type
- Research network
- Collaborators
- National Cancer Institute (NCI)
- Responsible party
- Sponsor
- Investigators
- Heather Greenlee, PhD, ND, Study chair, Herbert Irving Comprehensive Cancer CenterDawn Hershman, MD, Study chair, Herbert Irving Comprehensive Cancer Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01453452
- Sponsor's protocol ID
- S1008
- Other IDs
- S1008, U10CA037429, NCI-2011-03539
- Status last verified
- Jan 2020
- First submitted
- 14 Oct 2011
- Last updated
- 18 Jan 2020
- Results posted
- No
- Data monitoring committee
- Yes
Publications
Greenlee H, Lew DL, Hershman DL, Newman VA, Hansen L, Hartman SJ, Korner J, Shi Z, Sardo Molmenti CL, Sayegh A, Fehrenbacher L, Lo S, Klemp J, Rinn K, Robertson JM, Unger J, Gralow J, Albain K, Krouse R, Fabian C. Phase II Feasibility Study of a Weight Loss Intervention in Female Breast and Colorectal Cancer Survivors (SWOG S1008). Obesity (Silver Spring). 2018 Oct;26(10):1539-1549. doi: 10.1002/oby.22269. Epub 2018 Sep 11.
PubMed 30272836
Study at a glance
From the registry record, last updated by the sponsor on 18 Jan 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- S1008: Feasibility Study of a Physical Activity and Dietary Change Weight Loss Intervention In Breast and Colorectal Cancer Survivors, Phase II
- ClinicalTrials.gov ID
- NCT01453452
- Acronym / sponsor ID
- S1008
- Conditions
- Anxiety Disorder, Breast Cancer, Cognitive/Functional Effects, Colorectal Cancer, Depression, Fatigue
- Keywords
- weight changes, fatigue, depression, anxiety disorder, pain, cognitive/functional effects, psychosocial effects of cancer and its treatment, cancer survivor
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 50 participants (actual)
- Lead sponsor
- SWOG Cancer Research NetworkResearch network
- Collaborators
- National Cancer Institute (NCI)
- Study start
- Mar 2012
- Primary completion
- Aug 2015 (actual)
- Study completion
- Jan 2017 (actual)
- First posted
- 17 Oct 2011 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
RATIONALE: Physical activity, diet, and counseling may help breast and colorectal cancer survivors to lose weight and improve their quality of life.
PURPOSE: This phase II trial studies how well exercise, diet, and counseling work in improving physical activity and weight loss in overweight women who are breast and colorectal cancer survivors.
Detailed description
OBJECTIVES:
Primary
- To determine the feasibility of a 12-month community-based combined physical activity and dietary change weight-loss intervention in overweight and sedentary female breast and colorectal cancer survivors recruited via the Southwest Oncology Group (SWOG).
- To estimate the effect size of the intervention on weight loss at 12 months.
Secondary
- To measure changes in anthropometric measures from baseline (body mass index [BMI], waist and hip circumference) at 6 and 12 months and body composition (% body fat as assessed by dual-energy X-ray absorptiometry [DXA] scan) at 12 months.
- To measure changes in minutes spent per week in moderate-to-vigorous aerobic activity from baseline using Curves attendance records and a 7-day physical activity assessment at 6 and 12 months.
- To measure changes from baseline to 6 and 12 months in dietary intake of carotenoids via serum carotenoid measures.
- To assess changes from baseline to 6 and 12 months in perceived benefit of dietary change, physical activity, and weight loss after a cancer diagnosis.
- To measure changes from baseline in metabolic and hormonal biomarkers associated with breast and colorectal cancer recurrence risk (fasting insulin, fasting glucose, hemoglobin A1C, bioavailable estradiol, free testosterone, and adiponectin) at 6 and 12 months.
- To assess changes from baseline in anxiety, depression, fatigue, sleep, satisfaction with social roles, pain, and physical function using the PROMISE-43 at 6 and 12 months.
- To assess baseline predictors (medical history, health behaviors, quality of life) of subjects who adhere to and complete the intervention.
- To assess the diversity of subjects who enroll and complete the intervention.
- To assess the availability and acceptability of the Curves fitness centers at 12 months.
- To explore changes in DNA methylation.
- To assess the intervention and study process via open-ended interviews with SWOG sites and Curves franchises.
- To measure changes in anthropometric measures and assess feasibility of extended follow-up at 24 and 36 months.
- To assess the safety of the Curves® fitness centers for this population by assessing self-reported changes in lymphedema and any injuries as measured at 6 and 12 months.
OUTLINE: Participants are stratified according to type of cancer (breast vs colorectal).
Participants are instructed to practice 30-45 minutes of medium-to-hard exercise 5-7 days a week at a Curves fitness center (paid by study) or outside Curves for 12 months. Participants receive written materials on physical activity guidelines for survivors and a pedometer to track their physical activity outside Curves. They also receive the Curves Fitness \& Weight Management Plan and are instructed to follow a "higher carbohydrate" diet plan, which promotes a 1,500 kcal/day diet that is high in fruit and vegetables consisting of 30% protein, 45% carbohydrates, and 25% fat. In addition, participants receive the dietary guidelines for cancer survivors, which recommend eating 5 or more servings of fruit/vegetables per day, a diet high in whole grains, low in saturated fat, low in sugary foods, and low in alcohol. Participants receive 14 behavioral-counseling sessions by telephone with the goal to increase intervention adherence and participation retention. Each session lasts 40 minutes and occurs weekly on weeks 1-5 and then every 6 weeks by month 6. Participants receive monthly email newsletters with health tips and motivational messages to encourage adherence and retention to the study program. Counselors also conduct three 24-hour dietary recall assessments and 1 physical activity assessment at 6 and 12 months.
Participants complete a PROMIS-43 quality-of-life questionnaire at 6 and 12 months via internet, mail, or telephone.
Participants also undergo blood sample collection at baseline and at 6 and 12 months for fasting glucose and insulin tests, and biomarker studies. Anthropometric measurements (height, weight, waist, and hip circumference) are also collected.
After completion of study intervention, participants are followed up at 24 and 36 months.
Study design
- Primary purpose
- Supportive care
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Exercise and Lifestyle counseling | Experimental | Behavioral: behavioral dietary intervention, Behavioral: exercise intervention, Other: counseling intervention, Procedure: quality-of-life assessmentPatients will receive behavioral dietary intervention \& counseling intervention by phone, exercise intervention at Curves(R) facility, and take a quality-of-life assessment online. |
Who may qualify
- Ages
- Up to 120 years
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| behavioral dietary interventionReduce caloric intake by 500 kcal/day, increase fruit and vegetable intake to 5 or more servings per day, and limit daily calories from fat to be < 30%. Diet will be measured using 3 repeated 24-hr diet recalls. Participants will receive information on the recommended dietary modifications via mailed materials and telephone counseling sessions. | Behavioural | Exercise and Lifestyle counseling |
| exercise intervention150 min/wk of moderate exercise through use of the Curves® centers, engage in physical activity outside of Curves®, and use pedometers to track activity. | Behavioural | Exercise and Lifestyle counseling |
| counseling intervention14 40-min behavioral counseling sessions via telephone with the goal of increasing intervention adherence and increasing participant retention. | Other | Exercise and Lifestyle counseling |
| quality-of-life assessmentPROMIS-43 - online questionnaire to assess quality of life. | Procedure or surgery | Exercise and Lifestyle counseling |
Primary outcome
Attendance of ≥ 2 Curves sessions/week for a minimum of 36 of the 52 weeks of intervention
Time frame: 1 year from registration
Increase in fruit and vegetable consumption by 1 full serving per day (not including iceberg lettuce, potatoes, or fruit juices) OR reduce caloric intake by 100 kcal/day
Time frame: 1 year from registration
7 secondary outcomes
Changes in anthropometric measures (weight, BMI, waist circumference, hip circumference)
Time frame: 1 year from registration
Changes in body composition (% body fat as assessed by DXA scan at 12 months only)
Time frame: 1 year from registration
Changes in minutes spent per week in moderate-to-vigorous intensity aerobic activity using Curves attendance records and a 7-day physical activity recall assessment
Time frame: 1 year from registration
Changes in dietary intake patterns based on three separate 24-hour diet recalls
Time frame: 1 year from registration
Changes in metabolic and hormonal biomarkers associated with breast and colorectal cancer-recurrence risk (fasting insulin, fasting glucose, hemoglobin A1C, bioavailable estradiol, free testosterone, and adiponectin)
Time frame: 3 years
Changes in anxiety, depression, fatigue, sleep, satisfaction with social roles, pain, and physical function as measured by the PROMIS-43
Time frame: 1 year from registration
DNA methylation patterns
Time frame: 3 years
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 Jan 2020.
- Derived from this study: PubMed 30272836Greenlee H, Lew DL, Hershman DL, Newman VA, Hansen L, Hartman SJ, Korner J, Shi Z, Sardo Molmenti CL, Sayegh A, Fehrenbacher L, Lo S, Klemp J, Rinn K, Robertson JM, Unger J, Gralow J, Albain K, Krouse R, Fabian C. Phase II Feasibility Study of a Weight Loss Intervention in Female Breast and Colorectal Cancer Survivors (SWOG S1008). Obesity (Silver Spring). 2018 Oct;26(10):1539-1549. doi: 10.1002/oby.22269. Epub 2018 Sep 11.
Related trials for Anxiety Disorder
Not yet recruiting
Effect of Stress Ball Use During Femoral Arterial Sheath Removal After Coronary Angiography
Femoral Arterial Sheath Removal, Stress Ball
Recruiting
Unified Protocol in Penitentiary Facilities
Depression Disorders, Anxiety
Not yet recruiting
Preventive and Personalized Digital Emotion Regulation Skills Intervention to Reduce Depression and Anxiety in Youths With Adverse Childhood Experiences
Adverse Childhood Experience, Depression / Major Depressive Disorder
Recruiting
Effect of a Brief Daily Digital Meditation on Well-Being in US Young Adults (BEGIN II)
Mental Health and General Well-being
Not yet recruitingObservational study
Functional Impact of Psychological Symptoms in Patients With Superior Semicircular Canal Dehiscence Syndrome (SSCD): a National Cross-sectional Study
Superior Semicircular Canal Dehiscence
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Heather Greenlee, PhD, ND study chair
Herbert Irving Comprehensive Cancer Center
Dawn Hershman, MD study chair
Herbert Irving Comprehensive Cancer Center
58 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing behavioral dietary intervention, exercise intervention and counseling intervention in people with Anxiety Disorder and Breast Cancer, run by SWOG Cancer Research Network at 58 sites in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 18 Jan 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 58 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Attendance of ≥ 2 Curves sessions/week for a minimum of 36 of the 52 weeks of intervention (time frame: 1 year from registration). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT01453452, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jan 2020.